Motilal Oswal is bullish on Sun Pharma and has recommended buy rating on the stock with a target of Rs 600 in its September 12, 2013 research report.

Buy Sun Pharma; target Rs 535: Firstcall Research

Brokerage house Firstcall Research is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target price of Rs 535 in its August 24, 2013 research report.

Hold Sun Pharmaceuticals: Ventura

Ventura has recommended hold rating on Sun Pharmaceuticals Industries, in its May 29, 2013 research report. The research firm expects, the company to continue to grow on account of strong foothold in domestic market and robust growth in the international business.

Buy Sun Pharma; target Rs 1173: Firstcall Research

Firstcall Research is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target price of Rs 1173 in its May 29, 2013 research report.

Angel Broking neutral on Sun Pharma

Angel Broking has maintained neutral rating on Sun Pharma, in its February 08, 2013 research report.

Accumulate Sun Pharma; target of Rs 805: PLilladher

Prabhudas Lilladher is bullish on Sun Pharma and has recommended accumulate rating on the stock with a target of Rs 805 in its February 08, 2013 research report.

Motilal Oswal neutral on Sun Pharma

Motilal Oswal has maintained neutral rating on Sun Pharma with a target Rs 848, in its February 11, 2013 research report.

Buy Sun Pharma; target of Rs 734: IIFL

IIFL is bullish on Sun Pharma and has recommended buy rating on the stock with a target of Rs 734 in its January 23, 2013 research report.

Buy Sun Pharma; target of Rs 800: Emkay

Emkay Global Financial Services is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target of Rs 800 in its November 9, 2012 research report.

Sell Sun Pharma; target of Rs 638: Nirmal Bang

Nirmal Bang is bearish on Sun Pharma and has recommended sell rating on the stock with a target of Rs 638 in its August 13, 2012 research report.

Angel Broking neutral on Sun Pharma

Angel Broking has maintained neutral rating on Sun Pharma, in its June 1, 2012 research report.

Buy Sun Pharma; target of Rs 650: Emkay

Emkay Global Financial Services is bullish on Sun Pharma and has recommended buy rating on the stock with a target of Rs 650 in its May 30, 2012 research report.

Accumulate Sun Pharma; target Rs 586: Emkay

Emkay Global Financial Services is bullish on Sun Pharmaceutical Industries and has recommended accumulate rating on the stock with a target price of Rs 586 in its February 13, 2012 research report.

Motilal Oswal neutral on Sun Pharma

Motilal Oswal has maintained neutral rating on Sun Pharma with a target of Rs 614, in its February 15, 2012 research report.

Reduce Sun Pharma; target of Rs 534: PINC Research

PINC Research is bearish on Sun Pharma and has recommended reduce rating on the stock with a target of Rs 534 in its February 16, 2012 research report.

Reduce Sun Pharma; target of Rs 534: PINC Research

PINC Research is bearish on Sun Pharma and has recommended reduce rating on the stock with a target of Rs 534 in its February 13, 2012 research report.

Unicon recommends 8 stocks for long term investment

Unicon Investment has come out with its report on leveraged companies. The broking firm has identified have identified 8 companies with strong growth trajectories and debt to equity ratio less than or equal to one

Buy Sun Pharma; target Rs 569: Angel Broking

Angel Broking is bullish on Sun Pharma and has recommended buy rating on the stock with a target price of Rs 569 in its November 16, 2011 research report.

Sell Sun Pharma; target of Rs 450: Aditya Birla Money

Aditya Birla Money is bearish on Sun Pharma and has recommended sell rating on the stock with a target of Rs 450 in its August 12, 2011 research report.

Hold Sun Pharma; target of Rs 482: PINC Research

PINC Research has maintained hold rating on Sun Pharmaceutical Industries with a target price of Rs 482 in its July 29, 2011 research report.

Check out: Which stocks is Sharekhan betting on

Sharekhan has come with its report on various stocks.

Sell Sun Pharma; target of Rs 430: Aditya Birla Money

Aditya Birla Money is bearish on Sun Pharma and has recommended sell rating on the stock with a target of Rs 430 in its June 9, 2011 research report.

Accumulate Sun Pharma; target of Rs 518: Angel Broking

Angel Broking is bullish on Sun Pharma and has recommended accumulate rating on the stock with a target of Rs 518 in its May 30, 2011 research report.

Emkay recommends 8 stocks to buy for month of June

Emkay Global Financial Services has come out with its report on various stocks.

Buy Sun Pharma; target of Rs 487: Firstcall Research

Firstcall Research is bullish on Sun Pharma and has recommended buy rating on the stock with a target of Rs 487 in its March 8, 2011 research report.